In this study, Enzyme-Linked Immunosorbent Assay (ELISA), quantitative reverse-transcription (qRT)-PCR and immunohistochemistry (IHC) were used to evaluate the plasma and intervertebral disc expression levels of GSDMC in LDD patients and healthy controls. This evidence concerns the gene GSDMC and Lhermitte-Duclos disease.